Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
European Psychiatry : the Journal of the Association of European Psychiatrists|May 28, 2008
Depression, comorbidities and the TNF-alpha systemH Himmerich, S Fulda, J Linseisen, et al.
Journal of Neuroimmunology|February 12, 2015
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 geneS Nischwitz, C Wolf, T F M Andlauer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 9, 2008
The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disordersC K Thoeringer, S Ripke, P G Unschuld, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 22, 2003
Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH testH E Künzel, E B Binder, T Nickel, et al.
Acta Neurologica Scandinavica|September 21, 2010
More CLEC16A gene variants associated with multiple sclerosisS Nischwitz, S Cepok, A Kroner, et al.
Molecular Psychiatry|January 7, 2009
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depressionS Kloiber, M A Kohli, T Brueckl, et al.
Journal of Psychiatric Research|May 2, 2015
Poor sleep quality is associated with impaired glucose tolerance in women after gestational diabetesU Ferrari, H Künzel, K Tröndle, et al.
Acta Psychiatrica Scandinavica|November 22, 2007
Is MAO-B activity in platelets associated with the occurrence of suicidality and behavioural personality traits in depressed patients?U Lewitzka, B Müller-Oerlinghausen, W Felber, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 12, 2011
The validity of self-rated psychotic symptoms in depressed inpatientsF Seemüller, M Riedel, M Obermeier, et al.
ESMO Open|August 1, 2024
A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignanciesG Curigliano, M M Jimenez, T Shimizu, et al.
Pageof 5